MedPath

Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

Not Applicable
Completed
Conditions
Erectile Dysfunction
Interventions
Behavioral: Cognitive Behavioral Psychotherapy
Combination Product: Combined or Integrated Therapy
Other: Placebo
Registration Number
NCT04126252
Lead Sponsor
International Islamic University, Islamabad
Brief Summary

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
116
Inclusion Criteria
  • Men diagnosed with erectile dysfunction
  • Must be in the age range of 18 to 40 years
  • Must be in a stable heterosexual relationship
  • Must not be suffering from any medical or psychiatric illness
Exclusion Criteria
  • Men not meeting criteria of diagnosis of erectile dysfunction
  • Men not in a heterosexual relationship
  • Men above the age of 40 years
  • Men diagnosed with any medical or psychiatric illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Group ASildenafil Citrate 50Mg TabThis arm received pharmacotherapy for erectile dysfunction.
Group BCognitive Behavioral PsychotherapyThis arm received cognitive behavior psychotherapy for erectile dysfunction.
Group CCombined or Integrated TherapyThis arm received combined treatment approach.
Group DPlaceboThis arm acted as a control group and received placebo or no intervention.
Primary Outcome Measures
NameTimeMethod
International Index of Erectile Functioning-53 months maximum
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ahmad Bilal Private Practice

🇵🇰

Bahāwalpur, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath